The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors
Matrix metalloproteinases (MMPs) have been demonstrated to have both detrimental and protective functions in inflammatory diseases. Several MMP inhibitors, with the exception of Periostat<sup>®</sup>, have failed in Phase III clinical trials. As an alternative strategy, recent efforts ha...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | Nabangshu Das, Colette Benko, Sean E. Gill, Antoine Dufour |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-12-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/1/31 |
Similar Items
Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01)
by: Helena Laronha, et al.
Published: (2020-05-01)
Matrix Metalloproteinase Inhibitors (MMPIs) from Marine Natural Products: the Current Situation and Future Prospects
by: Se-Kwon Kim, et al.
Published: (2009-03-01)
by: Se-Kwon Kim, et al.
Published: (2009-03-01)
Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01)
by: Helena Laronha, et al.
Published: (2020-04-01)
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
by: Michele Provenzano, et al.
Published: (2020-01-01)
by: Michele Provenzano, et al.
Published: (2020-01-01)
Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis
by: Daniela Mendoza-Juárez, et al.
Published: (2025-09-01)
by: Daniela Mendoza-Juárez, et al.
Published: (2025-09-01)
Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
by: Shriefa Almutairi, et al.
Published: (2023-07-01)
by: Shriefa Almutairi, et al.
Published: (2023-07-01)
Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines
by: Yihe Wang, et al.
Published: (2022-08-01)
by: Yihe Wang, et al.
Published: (2022-08-01)
Diverse functions of matrix metalloproteinases during fibrosis
by: Matthew Giannandrea, et al.
Published: (2014-02-01)
by: Matthew Giannandrea, et al.
Published: (2014-02-01)
Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)
by: Helena Laronha, et al.
Published: (2021-03-01)
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
by: Gregg B. Fields
Published: (2019-08-01)
by: Gregg B. Fields
Published: (2019-08-01)
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
by: Maryam Raeeszadeh-Sarmazdeh, et al.
Published: (2020-05-01)
by: Maryam Raeeszadeh-Sarmazdeh, et al.
Published: (2020-05-01)
Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)
T Cell Control of Extracellular Matrix Degradation
by: Yves St-Pierre, et al.
Published: (2000-01-01)
by: Yves St-Pierre, et al.
Published: (2000-01-01)
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)
Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8
by: Shravan Morla, et al.
Published: (2020-08-01)
by: Shravan Morla, et al.
Published: (2020-08-01)
Matrix metalloproteinases and their inhibitors
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)
by: O. S. Grigorkevich, et al.
Published: (2019-02-01)
Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
by: K. P. Lactionov, et al.
Published: (2014-07-01)
by: K. P. Lactionov, et al.
Published: (2014-07-01)
Tissue inhibitors of metalloproteinases (TIMPs) modulate platelet ADAM10 activity
by: Christine Shu Mei Lee, et al.
Published: (2023-12-01)
by: Christine Shu Mei Lee, et al.
Published: (2023-12-01)
The predictive function of rates of matrix metalloproteinases/inhibitors system when assessing reparative changes in the lung tissue in those with infiltrate pulmonary tuberculosis
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)
by: D. S. Esmedlyaevа, et al.
Published: (2018-10-01)
The possibilities of using the inhibitors of matrix metalloproteinases for keratoplasty
by: K. V. Sirotkina, et al.
Published: (2023-09-01)
by: K. V. Sirotkina, et al.
Published: (2023-09-01)
Effects of Hormones on the Expression of Matrix Metalloproteinases and Their Inhibitors in Bovine Spermatozoa
by: Sang-Hwan Kim, et al.
Published: (2013-03-01)
by: Sang-Hwan Kim, et al.
Published: (2013-03-01)
Changes in Serum Levels of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Essential Hypertension
by: Krasimir Kostov, et al.
Published: (2022-03-01)
by: Krasimir Kostov, et al.
Published: (2022-03-01)
The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)
by: V. V. Kachkovska, et al.
Published: (2023-12-01)
Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets
by: Ella E. Aitchison, et al.
Published: (2025-04-01)
by: Ella E. Aitchison, et al.
Published: (2025-04-01)
Activity of matrix metalloproteinases and their tissue inhibitors in serum in chronic granulating periodontitis
by: D. I. Haidash, et al.
Published: (2019-12-01)
by: D. I. Haidash, et al.
Published: (2019-12-01)
Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
by: Shinji Takai, et al.
Published: (2022-10-01)
by: Shinji Takai, et al.
Published: (2022-10-01)
Role of Matrix Metalloproteinases and Their Inhibitors in Locally Invasive Papillary Thyroid Cancer
by: Irena Ivković, et al.
Published: (2022-12-01)
by: Irena Ivković, et al.
Published: (2022-12-01)
Matrix Metalloproteinases: Pathophysiologic Implications and Potential Therapeutic Targets in Cardiovascular Disease
by: Daniela Maria Tanase, et al.
Published: (2025-04-01)
by: Daniela Maria Tanase, et al.
Published: (2025-04-01)
Activity of genes of matrix metalloproteinases and their inhibitors in the Ligamentum flavum of patients with stenosing processes in spinal canal and dural sac
by: L. V. Rodionova, et al.
Published: (2021-12-01)
by: L. V. Rodionova, et al.
Published: (2021-12-01)
The relevance applying in the adhesive protocol in devital teeth
by: Z. S. Khabadze, et al.
Published: (2021-05-01)
by: Z. S. Khabadze, et al.
Published: (2021-05-01)
METALLOPROTEINASE AND ATHEROSCLEROSIS
by: Ya. V. Polonskaya, et al.
Published: (2017-09-01)
by: Ya. V. Polonskaya, et al.
Published: (2017-09-01)
Content of matrix metalloproteinases in the blood of hypertensive patients with a high cardiovascular risk receiving statin therapy
by: V. P. Mikhin, et al.
Published: (2022-11-01)
by: V. P. Mikhin, et al.
Published: (2022-11-01)
Distinct endobronchial expression of matrix-metalloproteinases (MMP) and their endogenous inhibitors in lung cancer
by: F Reichenberger, et al.
Published: (2001-05-01)
by: F Reichenberger, et al.
Published: (2001-05-01)
Shaping the Landscape of Lung Cancer: The Role and Therapeutic Potential of Matrix Metalloproteinases
by: Arghavan Ashja Ardalan, et al.
Published: (2024-11-01)
by: Arghavan Ashja Ardalan, et al.
Published: (2024-11-01)
Plasma Markers of Degradation of Extracellular Matrix with Intrauterine Herpes Infection
by: S. N. Beniova, et al.
Published: (2016-11-01)
by: S. N. Beniova, et al.
Published: (2016-11-01)
Mendelian Randomization Study of the Relationship Between Serum Matrix Metalloproteinases and the Occurrence of Sepsis
by: Changzhen Yang, et al.
Published: (2023-07-01)
by: Changzhen Yang, et al.
Published: (2023-07-01)
Gender peculiarities and prognostic value of matrix metalloproteinase and their inhibitors system in patients with acute Q-wave left ventricle myocardial infarction
by: S. M. Kyselov
Published: (2015-02-01)
by: S. M. Kyselov
Published: (2015-02-01)
Altered gene expression of selected matrix metalloproteinase system proteins in the broiler chicken gastrointestinal tract during post-hatch development and coccidia infection1
by: Anna Hrabia, et al.
Published: (2022-08-01)
by: Anna Hrabia, et al.
Published: (2022-08-01)
Association of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels with diabetic foot ulcer in Egyptians with type 2 diabetes mellitus
by: Ghada H Sayed, et al.
Published: (2018-01-01)
by: Ghada H Sayed, et al.
Published: (2018-01-01)
Matrix Metalloproteinases in Ureteropelvic Junction Obstruction: Their Role in Pathogenesis and Their Use as Clinical Markers
by: Giusi Alberti, et al.
Published: (2025-03-01)
by: Giusi Alberti, et al.
Published: (2025-03-01)
Similar Items
-
Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01) -
Matrix Metalloproteinase Inhibitors (MMPIs) from Marine Natural Products: the Current Situation and Future Prospects
by: Se-Kwon Kim, et al.
Published: (2009-03-01) -
Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01) -
The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
by: Michele Provenzano, et al.
Published: (2020-01-01) -
Matrix Metalloproteinase Inhibitors and Their Potential Clinical Application in Periodontitis
by: Daniela Mendoza-Juárez, et al.
Published: (2025-09-01)
